MedTrace Logo

Aromatherapy for Anxiety Among Children With Autism Spectrum Disorder

NCT03818490 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2019-01-28

No results posted yet for this study

Summary

This study evaluated the use of bergamot aromatherapy in the treatment of anxiety in a medical office setting among children who are diagnosed with an autism spectrum disorder. H

Conditions

Interventions

OTHER

Bergamot Aromatherapy

Patients in this group inhaled bergamot essential oil for 15 minutes.

Sponsors & Collaborators

  • Nutraceuticals Research Institute

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-24
Primary Completion
2018-03-09
Completion
2018-03-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03818490 on ClinicalTrials.gov